Antiviral Fails in Ebola, but Encouraging in Adenovirus

An investigational antiviral drug that was used to treat the Dallas Ebola patient showed potent virologic activity against a more common target, adenovirus, researchers said here. In a small pilot study, brincidofovir also appeared to be associated with better survival, compared with historical controls, among patients with adenovirus infection, according to Jo-Anne Young, MD, of the University of Minnesota in Minneapolis. http://www.medpagetoday.com/MeetingCoverage/IDWeek/48055?xid=nl_mpt_DHE_2014-10-13&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=ST&eun=g721819d0r&userid=721819&email=amydugan2%40gmail.com&mu_id=5883165&utm_term=Daily%20B